Dapagliflozin on Outcomes of Rhythm Control Strategy (Pharmacological ± Interventional) in Patient with Atrial Fibrillation

NCT06759909 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Dapagliflozin (Forxiga)
Atrial Fibrillation (AF)

Interventions

DRUG: Dapagliflozin (DAPA)

Sponsor

Assiut University